Brainstorm Cell Therapeutics Inc.
BCLI
Rank in Stocks
#28470
Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology firm dedicated to... Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology firm dedicated to the development and commercialization of personalized, autologous cellular therapies. These innovative treatments are specifically designed to address neurodegenerative diseases. At the heart of its strategy is the proprietary NurOwn cell therapy platform. This platform employs sophisticated cell culture techniques to prompt mesenchymal stem cells, derived from the patient's own bone marrow, to produce high concentrations of neurotrophic factors. This process aims to regulate neuroinflammatory and neurodegenerative disease mechanisms, bolster the survival of neurons, and ultimately enhance neurological function. NurOwn is currently undergoing significant clinical development, having completed a Phase III clinical trial for Amyotrophic Lateral Sclerosis (ALS). Additionally, it has successfully advanced through Phase II clinical trials for both progressive multiple sclerosis and Alzheimer's disease, with potential applications being explored for other neurodegenerative conditions. To support its therapeutic pipeline, the company has established a manufacturing partnership with Catalent for NurOwn. Incorporated in 2000, the company initially operated as Golden Hand Resources Inc. before adopting the name Brainstorm Cell Therapeutics Inc. in November 2004. Its corporate headquarters are situated in New York, New York.
Share Price
$0.99
Last synced: 2026-11-11
Market Cap
$10.92M
Change (1 day)
1.76%
Change (1 year)
54.69%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Brainstorm Cell Therapeutics Inc. (BCLI)
Category
Healthcare
Stock split history for Brainstorm Cell Therapeutics Inc. (BCLI)
Brainstorm Cell Therapeutics Inc. stock (symbol: BCLI) underwent a total of 3 stock splits.
The most recent stock split occurred on Oct 01, 2024.
One BCLI share bought prior to Sep 04, 2003 would equal to 0.0088888888888889 BCLI shares today.
The most recent stock split occurred on Oct 01, 2024.
One BCLI share bought prior to Sep 04, 2003 would equal to 0.0088888888888889 BCLI shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| 2024-10-01 | 1:15 | x0.066666666666667 | x0.0088888888888889 |
| 2014-09-16 | 1:15 | x0.066666666666667 | x0.13333333333333 |
| 2003-09-04 | 2:1 | x2 | x2 |
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 1 | x100 |
BE
|
|
| 0 | - |
NL
|
Questions about Brainstorm Cell Therapeutics Inc.'s stock splits
How many times has Brainstorm Cell Therapeutics Inc. split its stock?
Brainstorm Cell Therapeutics Inc. (BCLI) has split its stock 3 times. The first split was on Sep 4, 2003 and the most recent on Oct 1, 2024.
How many shares would one Brainstorm Cell Therapeutics Inc. share bought before Sep 4, 2003 be today?
After all its stock splits, one share bought before Sep 4, 2003 would be 0.00888889 shares today.